Evidence map›Paper›PMID 41233792›Full record

ArticleBMC infectious diseases2025

Unsuspected drug shortage is impacting the German HIV PrEP supply - results of a cross-sectional survey show: majority of PrEP users had to stop or switch to on-demand PrEP and higher unmet PrEP demand among women, diverse individuals, and those in rural or small-town areas.

Daniel Schmidt, Göran Kirchner, Konstantinos Voulgaris, Martin Friebe, Viviane Bremer, Barbara Bartmeyer

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel SchmidtDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. SchmidtD@rki.de.
Göran KirchnerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Konstantinos VoulgarisDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Martin FriebeDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Viviane BremerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Barbara BartmeyerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the implications of HIV pre-exposure prophylaxis (PrEP) shortages, we conducted a survey among PrEP users and individuals interested in PrEP. The survey explored coping strategies, HIV prevention and sexual behavior and stress levels due to the drug shortages. Furthermore, barriers to PrEP access among people with unmet PrEP demand were investigated.

methodsAn anonymous online survey was conducted from 28.01.-27.02.2024. Recruitment occurred via social media, professional societies, network channels, and flyers at HIV specialists. Factors associated with high stress levels and unmet PrEP demand were investigated using multivariable logistic regression.

resultsAmong 926 PrEP users, most were male (98%), aged 31-45 (54%), identified as men (97%), lived in large cities (54%), and used PrEP daily (78%). Due to the shortage, 63% paused or switched to on-demand use. Most intended to resume PrEP once available (65%), followed by relying on condoms (41%) or reducing sexual partners (39%). High stress level was reported by 78%. Predictors of higher stress levels included feeling less protected against HIV and having more than 11 sexual partners; using on-demand PrEP with fewer than 20 monthly pills was significantly less likely. Unmet PrEP demand was more common among female and gender-diverse individuals and less common among those living in large cities.

conclusionsInvoluntary changes in PrEP use may have hindered users' ability to adapt sexual behavior, increasing HIV risks. PrEP users most at risk and most reliant on PrEP experienced greater psychological burden. Expanding PrEP education and outreach alongside with prescriber capacity is essential to ensure PrEP continuity and meet unmet PrEP demand. Individualized counseling could help to determine actual PrEP need and benefits. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdultCross-Sectional StudiesFemaleGermanyHumansMaleMiddle AgedRural PopulationSexual BehaviorSurveys and QuestionnairesYoung AdultAnti-HIV AgentsDrug supply shortageGermanyHIV pre-exposure prophylaxis (PrEP)Unmet PrEP demand

Identifiers

PMID41233792
PMCPMC12616934

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.